Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v4-FR
Language French French
Date Updated 2022-02-22 2021-07-19
Drug Identification Number 02328003 02328003
Brand name CARDIOLITE CARDIOLITE
Common or Proper name Kit for the Preparation of Technetium Tc99m Sestamibi for Injection Kit for the Preparation of Technetium Tc99m Sestamibi for Injection
Company Name LANTHEUS MI CANADA INC LANTHEUS MI CANADA INC
Ingredients TETRAKIS [CU TETRAKIS [CU
Strength(s) 1MG 1MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size Kits of 2, 5, 20, or 30 vials Kits of 2, 5, 20, or 30 vials
ATC code V09GX V09GX
ATC description
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2021-09-01 2021-09-01
Actual start date 2021-08-27
Estimated end date 2022-02-15 2021-12-01
Actual end date 2022-02-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments